BX Swiss TOP 30 CHF
1.386,27
PKT
+7,48
PKT
+0,54
%
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 23.09.11 | Roche hold | Société Générale Group S.A. (SG) | |
| 23.09.11 | Logitech buy | Vontobel Research | |
| 23.09.11 | Nestlé kaufen | Raiffeisen Centrobank AG | |
| 22.09.11 | Straumann hold | Société Générale Group S.A. (SG) | |
| 22.09.11 | Logitech buy | Vontobel Research | |
| 22.09.11 | Roche buy | UniCredit Research | |
| 20.09.11 | Zurich Insurance buy | ING | |
| 20.09.11 | Novartis buy | Vontobel Research | |
| 20.09.11 | UBS hold | Société Générale Group S.A. (SG) | |
| 20.09.11 | Holcim hold | Vontobel Research | |
| 19.09.11 | UBS buy | Vontobel Research | |
| 19.09.11 | Novartis buy | Vontobel Research | |
| 16.09.11 | UBS verkaufen | Independent Research GmbH | |
| 16.09.11 | Lonza hold | Vontobel Research | |
| 16.09.11 | UBS buy | Vontobel Research | |
| 15.09.11 | Kühne + Nagel International hold | ING | |
| 15.09.11 | Novartis neutral | Goldman Sachs Group Inc. | |
| 15.09.11 | Zurich Insurance hold | ING | |
| 15.09.11 | Kühne + Nagel International hold | Vontobel Research | |
| 15.09.11 | Zurich Insurance buy | Société Générale Group S.A. (SG) | |
| 15.09.11 | Lonza hold | Vontobel Research | |
| 14.09.11 | Novartis buy | Société Générale Group S.A. (SG) | |
| 14.09.11 | Sonova hold | Vontobel Research | |
| 14.09.11 | Novartis buy | Vontobel Research | |
| 14.09.11 | Lonza hold | Vontobel Research | |
| 12.09.11 | Swiss Re buy | Vontobel Research | |
| 12.09.11 | Lonza hold | Vontobel Research | |
| 09.09.11 | Novartis outperform | Credit Suisse Group | |
| 09.09.11 | UBS overweight | Morgan Stanley | |
| 09.09.11 | Julius Bär equal-weight | Morgan Stanley | |
| 09.09.11 | Sika buy | UBS AG | |
| 09.09.11 | ABB (Asea Brown Boveri) buy | UBS AG | |
| 09.09.11 | Sika buy | Vontobel Research | |
| 09.09.11 | Lonza hold | Vontobel Research | |
| 08.09.11 | Givaudan overweight | J.P. Morgan Cazenove | |
| 08.09.11 | Holcim buy | UBS AG | |
| 08.09.11 | Holcim neutral | J.P. Morgan Cazenove | |
| 08.09.11 | ABB (Asea Brown Boveri) overweight | J.P. Morgan Cazenove | |
| 08.09.11 | Holcim neutral | Nomura | |
| 08.09.11 | Novartis buy | Vontobel Research |